| 1 |
31163215 | Inhibition of human cytochrome P450 2A6 by 7-hydroxycoumarin analogues: Analysis of the structure-activity relationship and isoform selectivity. | 2019 Aug 1 |
3 |
| 2 |
27815364 | Predictors of Variation in CYP2A6 mRNA, Protein, and Enzyme Activity in a Human Liver Bank: Influence of Genetic and Nongenetic Factors. | 2017 Jan |
1 |
| 3 |
21362475 | Thiomers: Inhibition of cytochrome P450 activity. | 2011 Aug |
1 |
| 4 |
18840518 | Differences in simulated liver concentrations of toxic coumarin metabolites in rats and different human populations evaluated through physiologically based biokinetic (PBBK) modeling. | 2008 Dec |
1 |
| 5 |
15041069 | Effects of chronic exposure to low-level cadmium on renal tubular function and CYP2A6-mediated coumarin metabolism in healthy human subjects. | 2004 Mar 21 |
2 |
| 6 |
12708602 | Single copy of variant CYP2A6 alleles does not confer susceptibility to liver dysfunction in patients treated with coumarin. | 2003 Apr |
1 |
| 7 |
12185557 | Phenotypic polymorphism of CYP2A6 activity in a Chinese population. | 2002 Aug |
1 |
| 8 |
10781881 | CYP2A6: a human coumarin 7-hydroxylase. | 2000 Apr 3 |
2 |
| 9 |
9355936 | Hepatitis A impairs the function of human hepatic CYP2A6 in vivo. | 1997 Dec 5 |
1 |
| 10 |
9409631 | A single amino acid substitution (Leu160His) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin. | 1997 Sep |
1 |
| 11 |
8896890 | Induction of cytochrome P450 2A6 expression in humans by the carcinogenic parasite infection, opisthorchiasis viverrini. | 1996 Oct |
2 |
| 12 |
7756103 | CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in patients with liver and kidney diseases and epileptic patients. | 1995 Jan |
1 |